Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.
This report aims to provide a comprehensive presentation of the global market for Gynecological Cancers Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecological Cancers Therapeutics. This report contains market size and forecasts of Gynecological Cancers Therapeutics in global, including the following market information:
- Global Gynecological Cancers Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global Gynecological Cancers Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The presence of a strong pipeline and new drug approvals are critical reasons that will drive gynecological cancers therapeutics market growth. The pipeline for gynecological cancers treatment includes novel therapeutics such as targeted therapy products, gene therapy, and vaccines. These products are expected to change the course of gynecological cancer treatment as they are associated with advanced therapeutic mechanisms of action. Some of these mechanisms include cell cycle inhibition, angiogenesis inhibition, programmed death-ligand 1 (PD-L1) inhibition, and PARP inhibition. The approval of novel gynecological cancer therapeutics by the US FDA is increasing due to the efficiency of these drugs.
We surveyed the Gynecological Cancers Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecological Cancers Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gynecological Cancers Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Cervical Cancer
- Ovarian Cancer
- Endometrial Cancer
- Vaginal Cancer
- Vulvar Cancer
- Other
Global Gynecological Cancers Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gynecological Cancers Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Targeted Therapy
- Chemotherapy
Global Gynecological Cancers Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gynecological Cancers Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gynecological Cancers Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Gynecological Cancers Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AstraZeneca
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Merck & Co., Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gynecological Cancers Therapeutics, market overview.
Chapter 2: Global Gynecological Cancers Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Gynecological Cancers Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gynecological Cancers Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gynecological Cancers Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gynecological Cancers Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gynecological Cancers Therapeutics Overall Market Size
2.1 Global Gynecological Cancers Therapeutics Market Size: 2022 VS 2030
2.2 Global Gynecological Cancers Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gynecological Cancers Therapeutics Players in Global Market
3.2 Top Global Gynecological Cancers Therapeutics Companies Ranked by Revenue
3.3 Global Gynecological Cancers Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gynecological Cancers Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gynecological Cancers Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gynecological Cancers Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gynecological Cancers Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gynecological Cancers Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gynecological Cancers Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Cervical Cancer
4.1.3 Ovarian Cancer
4.1.4 Endometrial Cancer
4.1.5 Vaginal Cancer
4.1.6 Vulvar Cancer
4.1.7 Other
4.2 By Type - Global Gynecological Cancers Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gynecological Cancers Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Gynecological Cancers Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gynecological Cancers Therapeutics Market Size, 2022 & 2030
5.1.2 Targeted Therapy
5.1.3 Chemotherapy
5.2 By Application - Global Gynecological Cancers Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gynecological Cancers Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Gynecological Cancers Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gynecological Cancers Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Gynecological Cancers Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gynecological Cancers Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Gynecological Cancers Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gynecological Cancers Therapeutics Revenue, 2018-2030
6.3.2 US Gynecological Cancers Therapeutics Market Size, 2018-2030
6.3.3 Canada Gynecological Cancers Therapeutics Market Size, 2018-2030
6.3.4 Mexico Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gynecological Cancers Therapeutics Revenue, 2018-2030
6.4.2 Germany Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.3 France Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.4 U.K. Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.5 Italy Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.6 Russia Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Gynecological Cancers Therapeutics Market Size, 2018-2030
6.4.8 Benelux Gynecological Cancers Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gynecological Cancers Therapeutics Revenue, 2018-2030
6.5.2 China Gynecological Cancers Therapeutics Market Size, 2018-2030
6.5.3 Japan Gynecological Cancers Therapeutics Market Size, 2018-2030
6.5.4 South Korea Gynecological Cancers Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Gynecological Cancers Therapeutics Market Size, 2018-2030
6.5.6 India Gynecological Cancers Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gynecological Cancers Therapeutics Revenue, 2018-2030
6.6.2 Brazil Gynecological Cancers Therapeutics Market Size, 2018-2030
6.6.3 Argentina Gynecological Cancers Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, 2018-2030
6.7.2 Turkey Gynecological Cancers Therapeutics Market Size, 2018-2030
6.7.3 Israel Gynecological Cancers Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Gynecological Cancers Therapeutics Market Size, 2018-2030
6.7.5 UAE Gynecological Cancers Therapeutics Market Size, 2018-2030
7 Gynecological Cancers Therapeutics Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Gynecological Cancers Therapeutics Major Product Offerings
7.1.4 AstraZeneca Gynecological Cancers Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Gynecological Cancers Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Company Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. Gynecological Cancers Therapeutics Major Product Offerings
7.5.4 Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Merck & Co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gynecological Cancers Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gynecological Cancers Therapeutics Market Drivers in Global Market
Table 3. Gynecological Cancers Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gynecological Cancers Therapeutics in Global Market
Table 5. Top Gynecological Cancers Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gynecological Cancers Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gynecological Cancers Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gynecological Cancers Therapeutics Product Type
Table 9. List of Global Tier 1 Gynecological Cancers Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gynecological Cancers Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gynecological Cancers Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gynecological Cancers Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Gynecological Cancers Therapeutics Product Offerings
Table 32. AstraZeneca Gynecological Cancers Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Company Summary
Table 35. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Product Offerings
Table 36. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Company Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Product Offerings
Table 40. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. GlaxoSmithKline plc Company Summary
Table 43. GlaxoSmithKline plc Gynecological Cancers Therapeutics Product Offerings
Table 44. GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline plc Key News & Latest Developments
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Gynecological Cancers Therapeutics Product Offerings
Table 48. Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co., Inc. Key News & Latest Developments
List of Figures
Figure 1. Gynecological Cancers Therapeutics Segment by Type in 2022
Figure 2. Gynecological Cancers Therapeutics Segment by Application in 2022
Figure 3. Global Gynecological Cancers Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gynecological Cancers Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gynecological Cancers Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gynecological Cancers Therapeutics Revenue in 2022
Figure 8. By Type - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. AstraZeneca Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
